Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

Aim. To assess the efficacy of a long-acting form of the granulocyte colony-stimulating factor (G-CSF) empegfilgrastim in primary prevention of neutropenia in patients with advanced stages of classical Hodgkin lymphoma (cHL) who received intensive chemotherapy with reduced inter-cycle interval under...

Повний опис

Бібліографічні деталі

Автори:	Anna Anatolevna Spornik, N. S. Vasilev, A. A. Samoilova, A. A. Mamedova, V. S. Bogatyrev, E. G. Smirnova, A. A. Bannikova, A. A. Rukavitsyn, N. S. Shorokhov, N. E. Mochkin, V. O. Sarzhevskii, E. A. Demina, V. Ya. Melnichenko
Формат:	Artigo
Мова:	Russo
Опубліковано:	Practical Medicine Publishing House 2023-09-01
Серія:	Клиническая онкогематология
Предмети:	classical hodgkin lymphoma eacodd-14 eacoрр-14 empegfilgrastim treatment outcomes
Онлайн доступ:	https://bloodjournal.ru/index.php/coh/article/view/48
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!